[News on diabetes and public health perspectives].
Solignac
Marie
M
D000284:Administration, Oral; D000328:Adult; D002839:Chromans / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000503:physiopathology / Q000517:prevention & control; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control; D016640:Diabetes, Gestational / Q000517:prevention & control; D015444:Exercise; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007231:Infant, Newborn; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D009765:Obesity / Q000150:complications; D016035:Pancreas Transplantation; D010353:Patient Education as Topic; D011247:Pregnancy; D011634:Public Health; D012307:Risk Factors; D013844:Thiazoles / Q000008:administration & dosage / Q000627:therapeutic use; D045162:Thiazolidinediones; D013997:Time Factors; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D007328:Insulin; D013844:Thiazoles; D045162:Thiazolidinediones; D008687:Metformin; D000077288:Troglitazone